Skip to content
Optionomics Free · No account needed

Earnings analysis · 10-Q

SENS earnings analysis

Filed May 7, 2026 · Our reading of the company's report

The latest report

Senseonics Holdings, Inc. reported robust Q1 2026 results with revenues of $11.7 million, marking an 87% increase year-over-year and exceeding estimates by 18.7%. However, the company posted an EPS of -$0.71, which was…

Read full summary

Senseonics Holdings, Inc. reported robust Q1 2026 results with revenues of $11.7 million, marking an 87% increase year-over-year and exceeding estimates by 18.7%. However, the company posted an EPS of -$0.71, which was below the expected -$0.69, highlighting continuing challenges in profitability despite strong sales growth.

Read the original on SEC.gov

Gross and operating margin

How much of each revenue dollar the business keeps.

48% Gross margin Operating margin Mar 2024 Mar 2026

One point per quarterly or annual filing. Both margins are shares of that report's revenue.

How we read each report

Our analysis across the last few reports.

Read as bullish Read as bearish Aug 2023 May 2026

Our model's reading of each filing, not the share price or the market's reaction. Annual and quarterly reports each occupy one position.

Reported figures

Earnings per share
$-0.71

What stood out

  • Strong Revenue Growth

    Q1 2026 revenue soared to $11.7 million, an 87% increase from the previous year.

  • Exceeded Revenue Estimates

    Revenue surpassed consensus estimates by 18.7%, beating the expected $9.87 million.

  • Enhanced Full-Year Guidance

    The company raised its full-year revenue guidance to $60-64 million from a previous $58-62 million.

  • Improved Market Performance

    The significant revenue increase reflects positive momentum in the U.S. market for the Eversense 365 product.

  • Operational Expansion in Europe

    Management expects to transition Eversense operations in Europe successfully, with significant expected revenue opportunities.

  • Increased Loan Capacity

    New amendments to the loan agreement with Hercules Capital now allow up to $140 million in borrowings.

What to watch

  • Operating Losses Persist

    Despite revenue growth, the company reported an operating loss of -215.6% as a percentage of revenue.

  • Increased Indebtedness Risk

    The amended loan agreement could lead to significant debt, raising vulnerability to economic shifts.

  • Execution Risks in European Expansion

    Delays in the European Asset Purchases could disrupt operations and affect revenue generation in those markets.

Management's outlook

Management has not provided explicit numeric EPS guidance but expects improved performance as operations normalize.

Earlier filings 4

10-K · March 2, 2026

Senseonics is transitioning commercial control of its Eversense CGM business back from Ascensia (U.S. asset purchase closed January 1, 2026) while ramping commercialization of the Eversense 365 (FDA approved September…

10-Q · August 6, 2025

SENS reported Q2 revenue of $6,649,000 (7.92% beat vs consensus) and EPS of $(0.02) which matched estimates. Gross margin expanded to 46.9% but the company remains loss-making with an operating margin of -215.4% and…

10-Q · May 8, 2025

Senseonics reported Q1 revenue of $6,257,000 (vs. estimate $5,570,000) and GAAP EPS of -$0.02, in line with consensus. Gross margin expanded to 24.1% year-over-year while operating losses remain substantial (operating…

10-Q · November 7, 2024

Senseonics reported quarterly revenue of $4,263,000 (a beat vs. consensus $4,080,000) but reported a loss per share of $0.04. The 10‑Q discloses management's conclusion that recurring losses, anticipated debt repayments…

This is our reading of a public filing, not the filing itself. Analysis can contain errors; check the source document for full context.